Funding for early phase clinical trials of natural products, including botanicals and dietary supplements, to assess impact on target engagement and patient outcomes.
This grant funds early phase clinical trials testing natural products like botanicals, probiotics, and dietary supplements with strong scientific backing for further testing.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NHLBI plans to fund single-site clinical trials (R61/R33) testing therapeutic, behavioral, or prevention strategies, encouraging innovative designs.
This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.